117 related articles for article (PubMed ID: 38724835)
1. Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.
Hatami Zharabad S; Mohammadian M; Zohdi Aghdam R; Hassanzadeh Dizaj M; Behrouzkia Z
Mol Biol Rep; 2024 May; 51(1):633. PubMed ID: 38724835
[TBL] [Abstract][Full Text] [Related]
2. Combination of NDRG2 overexpression, X-ray radiation and docetaxel enhances apoptosis and inhibits invasiveness properties of LNCaP cells.
Alizadeh Zarei M; Rafiei Dehbidi G; Takhshid MA
Urol Oncol; 2020 Nov; 38(11):849.e1-849.e9. PubMed ID: 32665121
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with silver graphene quantum dot, radiation, and 17-AAG induces anticancer effects in breast cancer cells.
Esgandari K; Mohammadian M; Zohdiaghdam R; Rastin SJ; Alidadi S; Behrouzkia Z
J Cell Physiol; 2021 Apr; 236(4):2817-2828. PubMed ID: 32901933
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.
Bannister AH; Bromma K; Sung W; Monica M; Cicon L; Howard P; Chow RL; Schuemann J; Chithrani DB
Br J Radiol; 2020 Feb; 93(1106):20190742. PubMed ID: 31778316
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.
Mirjolet C; Boudon J; Loiseau A; Chevrier S; Boidot R; Oudot A; Collin B; Martin E; Joy PA; Millot N; Créhange G
Int J Nanomedicine; 2017; 12():6357-6364. PubMed ID: 28919739
[TBL] [Abstract][Full Text] [Related]
6. Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.
Sato A; Itcho N; Ishiguro H; Okamoto D; Kobayashi N; Kawai K; Kasai H; Kurioka D; Uemura H; Kubota Y; Watanabe M
Int J Nanomedicine; 2013; 8():3151-60. PubMed ID: 23990723
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
Tamaki H; Harashima N; Hiraki M; Arichi N; Nishimura N; Shiina H; Naora K; Harada M
Oncotarget; 2014 Nov; 5(22):11399-412. PubMed ID: 25333266
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.
Moradi Z; Mohammadian M; Saberi H; Ebrahimifar M; Mohammadi Z; Ebrahimpour M; Behrouzkia Z
Daru; 2019 Jun; 27(1):111-119. PubMed ID: 30835081
[TBL] [Abstract][Full Text] [Related]
9. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
Singh SK; Lillard JW; Singh R
Cancer Lett; 2018 Jul; 427():49-62. PubMed ID: 29678549
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.
Zhu S; Oremo JA; Li S; Zhen M; Tang Y; Du Y
PLoS One; 2014; 9(3):e91817. PubMed ID: 24632829
[TBL] [Abstract][Full Text] [Related]
11. The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.
Rudner J; Ruiner CE; Handrick R; Eibl HJ; Belka C; Jendrossek V
Radiat Oncol; 2010 Nov; 5():108. PubMed ID: 21080918
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
[TBL] [Abstract][Full Text] [Related]
13. Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel.
Bromma K; Dos Santos N; Barta I; Alexander A; Beckham W; Krishnan S; Chithrani DB
Sci Rep; 2022 Aug; 12(1):13508. PubMed ID: 35931743
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
[TBL] [Abstract][Full Text] [Related]
15. Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line.
Cancino-Marentes ME; Hernández-Flores G; Ortiz-Lazareno PC; Villaseñor-García MM; Orozco-Alonso E; Sierra-Díaz E; Solís-Martínez RA; Cruz-Gálvez CC; Bravo-Cuellar A
BMC Urol; 2021 Mar; 21(1):38. PubMed ID: 33711972
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.
Eftekhari S; Montazeri H; Tarighi P
Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060
[TBL] [Abstract][Full Text] [Related]
18. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.
Nelius T; Martinez-Marin D; Hirsch J; Miller B; Rinard K; Lopez J; de Riese W; Filleur S
Cell Death Dis; 2014 May; 5(5):e1210. PubMed ID: 24810046
[TBL] [Abstract][Full Text] [Related]
20. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
